Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. - Test2 - elhamkhani - TriplyDB

Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis.

Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis.

http://www.wikidata.org/entity/Q35809534

about

Early detection of diabetic kidney disease: Present limitations and future perspectives Metabolomics of oxidative stress in recent studies of endogenous and exogenously administered intermediate metabolites Metabolomics and cardiovascular biomarker discovery Metabolomics tools for describing complex pesticide exposure in pregnant women in Brittany (France)Beneficial metabolic effects of 2',3',5'-tri-acetyl-N6- (3-hydroxylaniline) adenosine in the liver and plasma of hyperlipidemic hamsters Plasma metabolomic profiling to reveal antipyretic mechanism of Shuang-huang-lian injection on yeast-induced pyrexia rats Biomarkers, metabonomics, and drug development: can inborn errors of metabolism help in understanding drug toxicity?The metabolic signature related to high plant growth rate in Arabidopsis thaliana Protein Bioinformatics Infrastructure for the Integration and Analysis of Multiple High-Throughput "omics" Data.Potential metabolic mechanism of girls' central precocious puberty: a network analysis on urine metabonomics data.Chemometric Resolution and Quantification of Four-Way Data Arising from Comprehensive 2D-LC-DAD Analysis of Human Urine.Differential effects of dry eye disorders on metabolomic profile by 1H nuclear magnetic resonance spectroscopy ANOVA-simultaneous component analysis (ASCA): a new tool for analyzing designed metabolomics data.Plant metabolomics: from holistic hope, to hype, to hot topic.Metabolic profiling of patients with schizophrenia TargetSearch--a Bioconductor package for the efficient preprocessing of GC-MS metabolite profiling data.Medium chain acylcarnitines dominate the metabolite pattern in humans under moderate intensity exercise and support lipid oxidation Metabolic Profiling Analysis of the Alleviation Effect of Treatment with Baicalin on Cinnabar Induced Toxicity in Rats Urine and Serum Integrating transcriptomics and metabonomics to unravel modes-of-action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in HepG2 cells.Cross-platform analysis of longitudinal data in metabolomics.Metabolic differences underlying two distinct rat urinary phenotypes, a suggested role for gut microbial metabolism of phenylalanine and a possible connection to autism.Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics.The acute inflammatory response in trauma / hemorrhage and traumatic brain injury: current state and emerging prospects.Metabolic control of oocyte development: linking maternal nutrition and reproductive outcomes The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses Applying (1)H NMR Spectroscopy to Detect Changes in the Urinary Metabolite Levels of Chinese Half-Pipe Snowboarders after Different Exercises.NMR Metabolomics Analysis of Parkinson's Disease Metabolomics and renal disease.A proton nuclear magnetic resonance-based metabonomics study of metabolic profiling in immunoglobulin a nephropathy.Application of metabolomics in traditional chinese medicine differentiation of deficiency and excess syndromes in patients with diabetes mellitus.How molecular profiling could revolutionize drug discovery.Metabonomic signature analysis of cervical carcinoma and precancerous lesions in women by (1)H NMR spectroscopy.Advances in gas chromatographic methods for the identification of biomarkers in cancer.Biomarkers for amyotrophic lateral sclerosis.Metabonomics in preclinical drug development.Metabolic profiling technologies for biomarker discovery in biomedicine and drug development.Serum Metabolite Profiles Are Altered by Erlotinib Treatment and the Integrin α1-Null Genotype but Not by Post-Traumatic Osteoarthritis Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer.Effect of acupuncture and its influence on cerebral activity in functional dyspepsia patients: study protocol for a randomized controlled trial.Global metabolic profiling and its role in systems biology to advance personalized medicine in the 21st century.

P2860

Q26741494-5853F3B8-06C4-4027-A96E-829119B3C34D Q26824720-BFF9BD85-D07B-41DF-9FFD-9B8B6BF67846 Q26991473-42234080-EB18-4BBC-B1CB-E90190199534 Q28383230-64193C8F-39F4-47C1-BA20-D73DD7B0D5D6 Q28481695-D579013A-E3DE-4447-9406-974AA1553268 Q28539818-DC145CD4-29D7-4A0B-B5EC-78640148FB6E Q28751300-F49E9612-64DC-4B72-9E94-4FC1642F916F Q28763313-E8931C1D-E3A3-499F-B263-A1C516C55364 Q30387712-05F04D01-6AA3-4390-8B44-B134E7D62813 Q30584137-8F260B0B-66A5-470C-B148-F20BAC93A2A4 Q30665507-2A3E4E88-8A61-4EE8-9616-B7E866ADF6DD Q30833462-DD5D8A8A-1896-43B1-B4C1-0B8E30E6584F Q30989683-4909F8D1-7596-49CB-B656-42CDDBAE12F0 Q33231588-E205B5EE-3D83-4836-8679-8EBF42B8E0F7 Q33255317-DC094C0F-3A00-491C-A28B-066987DA8C4B Q33518931-BC5DBCD7-83B6-4710-BEAC-A53DC6D06CE9 Q33633988-CB5FEC86-44E0-40F1-B8F6-7A7713308FD7 Q33695082-0AAC952B-EC48-4EDA-BB56-E18900B825DC Q34006474-2BB7C21E-BCE2-4A21-BFA1-03BC09003A22 Q34030471-3F4515DD-2231-44C2-A7E5-1B3A5192FB3C Q34252098-54C9B8C3-9FE2-44AD-8E57-5638ABFC3EE6 Q34555598-F852FC7F-E462-4C99-8695-7B7AF54CECD9 Q34736071-461B8836-47F7-406A-9016-A96F0012642C Q35318639-608285C6-6CEE-466A-B9D1-775BE278D723 Q35527861-F6969010-590C-4B99-9121-0D545DF1B312 Q35691494-931ED932-F395-47BA-808B-033CD55BA05B Q35734379-A62843E2-9ED4-464A-8F16-33419CFE71C2 Q35778649-3764FE21-E7B5-419D-8EB7-C0D192EFB92C Q35864994-E611A19B-1EFA-416F-9B19-AD6D3724C626 Q36063502-CE67F4F6-2DE6-4DB8-8F27-3154936548FF Q36079232-FF51848E-BDA7-4F62-8DBC-5C861398B1CA Q36224709-A6BA9F27-63F8-4D27-A5CD-E9DDA898D613 Q36316592-2AA23CDE-86C9-46C8-9395-3CF7F7835B6F Q36481118-80DCE889-E2F2-45AA-839C-50CC3296B0F1 Q36544940-AC24E4EF-E0B8-4F43-BECE-B956220DD5C7 Q36629997-12F7D513-083C-4F11-99EB-9F1DAE9C5A38 Q36654870-653DC694-7780-411E-A964-A7E4701F9A89 Q36680439-1BD14A66-3405-49A3-9640-35531FA69E67 Q36759762-9CE73859-12AC-4601-9FE6-FABB422408E8 Q36816026-82F79415-6132-46DA-A493-C2A718D52621

P2860

Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis.

http://www.wikidata.org/entity/Q35809534

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Metabonomics technologies and ...... essment and disease diagnosis.

@ast

Metabonomics technologies and ...... essment and disease diagnosis.

@en

type

label

Metabonomics technologies and ...... essment and disease diagnosis.

@ast

Metabonomics technologies and ...... essment and disease diagnosis.

@en

prefLabel

Metabonomics technologies and ...... essment and disease diagnosis.

@ast

Metabonomics technologies and ...... essment and disease diagnosis.

@en

P1433

Q35809534-BE28465E-D95E-446F-9545-6B09E1E34E9B

P1476

Q35809534-6F656DF3-8795-4EFA-8B34-6AD8E5E869CB

P2093

Q35809534-1C57072E-250C-4E75-904C-D1CF8BBEF231

Q35809534-819FD5A3-B854-4A2E-B99E-4D39FF71661E

Q35809534-E353246F-7276-403D-9520-158569DC127E

Q35809534-EB43DBF7-1C71-4C45-ACE2-3B44A9758084

P2860

Q35809534-0C89D6DC-975C-4D7D-8817-E68577242BC8

Q35809534-0F1CEF70-88BB-4DD6-AB62-4C452FB5B6E8

Q35809534-2A837035-36B1-4DC4-9813-5C45F3AF000B

Q35809534-2D0E962E-9E5F-4064-AD4E-F7AC2972477A

Q35809534-2F9923BE-A5DF-45DF-B002-EF773935F403

Q35809534-31B4A989-6F44-4F69-8320-214CBAA43C8E

Q35809534-46F1EC61-3796-43AA-BCAC-19585E8A88D2

Q35809534-48B35D6C-E56B-41F5-AA30-1639FCF72CD7

Q35809534-583A7DC9-98B5-4A6D-A9DF-599D5CDD7FF9

Q35809534-5B030347-DA59-46B0-9C0C-11AD8F913CBE

P304

Q35809534-14ABD665-56AA-444E-8E73-00E56AFED2D6

P31

Q35809534-3E9C0FE4-0EE9-43C5-8106-0F09580260DC

P356

Q35809534-F8C2490A-2B74-4DC6-A415-31806252842D

P433

Q35809534-184BC9B5-C659-43EA-87A1-7C294F84C322

P478

Q35809534-624B3099-F970-4E7B-B822-AC5511E7B0CE

P50

Q35809534-B838BBEF-2606-475D-8FC2-0704E6562436

P577

Q35809534-CE9ED720-3E76-439E-9498-370326EACDB2

P5875

Q35809534-4A13B3BE-2CBB-40AD-B0B6-F19340DC8105

P698

Q35809534-4432C4CC-CE7F-4FCA-B46F-6551A2A7545D

P356

13547500410001668379

P1433

P1476

Metabonomics technologies and ...... essment and disease diagnosis.

@en

P2093

Elaine Holmes

http://www.w3.org/2001/XMLSchema#string

Elizabeth G Stanley

http://www.w3.org/2001/XMLSchema#string

John C Lindon

http://www.w3.org/2001/XMLSchema#string

Mary E Bollard

http://www.w3.org/2001/XMLSchema#string

P2860

A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations

'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data

The biochemical profile of rat testicular tissue as measured by magic angle spinning 1H NMR spectroscopy.

High-resolution magic angle spinning 1H-NMR spectroscopy studies on the renal biochemistry in the bank vole (Clethrionomys glareolus) and the effects of arsenic (As3+) toxicity.

NMR and pattern recognition studies on the time-related metabolic effects of alpha-naphthylisothiocyanate on liver, urine, and plasma in the rat: an integrative metabonomic approach.

NMR-based metabonomic studies on the biochemical effects of epicatechin in the rat.

An automatic data reduction and transfer method to aid pattern recognition analysis and classification of NMR spectra.

NMR spectroscopy based metabonomic studies on the comparative biochemistry of the kidney and urine of the bank vole (Clethrionomys glareolus), wood mouse (Apodemus sylvaticus), white toothed shrew (Crocidura suaveolens) and the laboratory rat.

Metabonomics: a platform for studying drug toxicity and gene function.

P304

1-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13547500410001668379

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Jeremy K. Nicholson

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8504119

http://www.w3.org/2001/XMLSchema#string

P698

15204308

http://www.w3.org/2001/XMLSchema#string